Theravance Biopharma
TBPH
TBPH
121 hedge funds and large institutions have $431M invested in Theravance Biopharma in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 15 closing their positions.
Holders
121
Holders Change
+3
Holders Change %
+2.54%
% of All Funds
1.75%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
19
Increased
35
Reduced
47
Closed
15
Calls
$22K
Puts
$23K
Net Calls
-$1K
Net Calls Change
-$2.38M
Top Buyers
Top Sellers
1 |
BG
1
Baupost Group
Boston,
Massachusetts
|
$59.1M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$24.1M |
3 |
3
BlackRock
New York
|
$37.7M |
4 |
4
Jane Street
New York
|
$301K |
5 |
NM
5
Newtyn Management
New York
|
$14.7M |